Deep brain stimulation, stem cell treatment, studying mitochondria—to mark Parkinson’s Awareness Month, we review some noteworthy new concepts.
Alisa G. Woods, PhD
A new way to treat dementia and other diagnosis and treatment developments are in the news.
There’s a new app for tracking symptoms of Parkinson disease, Alzheimer and Parkinson diseases may share characteristics with mad cow disease, and a skin test may one day be used to detect both AD and PD.
Focused ultrasound works like a noninvasive knife, cutting away amyloid plaques in mice. But is this new method safe and effective in humans?
These agents lower cholesterol and prevent cardiovascular disease, but they may actually increase the risk of Parkinson disease. Caution advised.
Scientists are testing alternative therapeutic approaches that may delay disease progression and even protect and regenerate neurons.
Anticholinergics could confer an increased risk, one dependent on the dose and amount of use. Give them to older patients or consider alternatives?
Orexin B protects vulnerable midbrain neurons from degeneration and preserves their function. This sleep-promoting protein could provide a new target for potential treatments.
HDIT/HCT could induce sustained remission and neurological improvements in patients with multiple sclerosis.
Prostaglandin may block protective microglial cells in Alzheimer disease, a study shows. This work could form the basis for future therapies.